Metoprolol vs carvedilol in heart failure

Metoprolol vs carvedilol in heart failure

Bibliographic Details
Main Authors:	Norton Michael, Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas LD
Format:	Article
Language:	English
Published:	BMC 2000-10-01
Series:	Current Controlled Trials in Cardiovascular Medicine
Subjects:	?-blockers, heart failure, medical therapy
Online Access:	http://cvm.controlled-trials.com/paperreport/cvm-2001-72005

Similar Items

Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study
by: Køber Lars, et al.
Published: (2011-10-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort
by: Chao‐Hsiun Tang, et al.
Published: (2016-01-01)

Metoprolol and atenolol in mild-to-moderate chronic heart failure: The comparison of survival benefit
by: Ćelić Vera, et al.
Published: (2005-01-01)

Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study)
by: Paulo Roberto Chizzola, et al.
Published: (2000-03-01)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
by: Ki Hong Choi, et al.
Published: (2019-09-01)

Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure
by: Shirazi-Tehrani E, et al.
Published: (2020-09-01)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures
by: Aaron I. Vinik, et al.
Published: (2014-08-01)

Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart Failure
by: Firouzabadi N, et al.
Published: (2020-06-01)

Efeitos do tartarato de metoprolol em pacientes portadores de insuficiência cardíaca Effects of metoprolol tartrate therapy in patients with heart failure
by: José Albuquerque de Figueiredo Neto, et al.
Published: (2006-09-01)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results
by: Heather L. Bloom, et al.
Published: (2014-08-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality
by: Sara Corradetti, et al.
Published: (2022-05-01)

Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes
by: Carol T. Bussey, et al.
Published: (2020-03-01)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
by: Kenneth D. Varian, et al.
Published: (2020-10-01)

CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
by: William H Frishman, et al.
Published: (2008-12-01)

Possible genetic implications in the response to cardiac resynchronisation therapy in a patient affected by heart failure
by: Natalia Pezzali, et al.
Published: (2011-06-01)

Heart Rate Reduction and Outcomes in Heart Failure Outpatients
by: Felix Memenga, et al.
Published: (2023-10-01)

Beta‐blocker use and mortality among patients with systolic heart failure and pacemaker rhythm
by: Andrew S. Perry, et al.
Published: (2023-06-01)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
by: Kazufumi Nakamura, et al.
Published: (2011-08-01)

Effects of propranolol on the QT dispersion in congestive heart failure
by: Evandro Tinoco Mesquita, et al.
Published: (1999-09-01)

β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate
by: Jin Joo Park, et al.
Published: (2019-02-01)

Real-World Use of Carvedilol in Children With Dilated Cardiomyopathy: Long-Term Effect on Survival and Ventricular Function
by: Rachele Adorisio, et al.
Published: (2022-04-01)

Poor tolerance of beta-blockers by elderly patients with heart failure
by: Satoshi Yanagisawa, et al.
Published: (2010-11-01)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
by: Britt Kveiborg, et al.
Published: (2007-03-01)

Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research
by: Gad Cotter, et al.
Published: (2021-04-01)

WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Up-to date view on -blocker in treatment of arterial hypertension with heart failure
by: Galina Nikolaevna Gorokhovskaya, et al.
Published: (2009-03-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
by: Milos Taborsky, et al.
Published: (2021-11-01)

Sacubitril/valsartan vs. angiotensin receptor inhibition in heart failure: a real‐world study in Taiwan
by: Po‐Cheng Chang, et al.
Published: (2020-10-01)

Beta-blockers in chronic heart failure in elderly patient
by: Alberto De Bernardi
Published: (2009-06-01)

The role of heart rate and ivabradine in acute heart failure
by: Edoardo Sciatti, et al.
Published: (2019-10-01)

Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death?
by: Goldstein Sidney
Published: (2000-10-01)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
by: Tobias Schupp, et al.
Published: (2022-08-01)

The effect of beta-blockers in acute heart failure according to heart rate
by: Hyun-Jin Kim, et al.
Published: (2021-07-01)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
by: Valentina Carubelli, et al.
Published: (2021-06-01)

Factors associated with β-blocker initiation and discontinuation in a population-based cohort of seniors newly diagnosed with heart failure
by: Girouard C, et al.
Published: (2016-09-01)

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
by: Leenen Frans HH, et al.
Published: (2002-11-01)